Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF

Abstract

The p53 tumour-suppressor protein is tightly regulated through its association with the Hdm2 E3 ligase. Activation of p53 by DNA strand breaks is orchestrated by the ataxia-telangiectasia mutated (ATM) protein kinase and involves interruption of Hdm2-mediated p53 degradation. As part of this mechanism ATM itself, and the ATM-activated protein tyrosine kinase, c-Abl, inhibit Hdm2 function through phosphorylation of serine 395 and tyrosine 394 (Y394), respectively. In the present study, we have identified a novel target of c-Abl in the Hdm2 protein, tyrosine 276 (Y276). We show that c-Abl phosphorylates this residue in vitro and confirm that Y394 is a target of c-Abl. We also show that Y276 is phosphorylated in a c-Abl-dependent manner in cultured cells and provide evidence that Y276 is phosphorylated in response to DNA damage coincident with the activation of c-Abl. Finally, we show that Y276 phosphorylation stimulates interaction with ARF, leading to increased levels of nucleolar Hdm2 and decreased turnover of p53. These data establish Y276 as a physiological target of c-Abl that contributes functionally to the induction of p53.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Appella E, Anderson CW . (2001). Eur J Biochem 268: 2764–2772.

  • Barila D, Mangano R, Gonfloni S, Kretzschmar J, Moro M, Bohmann D et al. (2000). EMBO J 19: 273–281.

  • Blattner C, Hay TJ, Meek DW, Lane DP . (2002). Mol Cell Biol 22: 6170–6182.

  • Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW . (2001). J Mol Biol 314: 263–277.

  • Goldberg Z, Sionov RV, Berger M, Zwang Y, Perets R, Van Etten RA et al. (2002). EMBO J 21: 3715–3727.

  • Harris SL, Levine AJ . (2005). Oncogene 24: 2899–2908.

  • Kurki S, Peltonen K, Kiviharju T, Latonen L, Ojala P, Meek D et al. (2004). Cancer Cell 5: 465–475.

  • Lu X . (2005). Curr Opin Genet Dev 15: 27–33.

  • Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O et al. (2001). Genes Dev 15: 1067–1077.

  • Meek DW, Knippschild U . (2003). Mol Cancer Res 1: 1017–1026.

  • Michael D, Oren M . (2003). Semin Cancer Biol 13: 49–58.

  • Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace Jr AJ et al. (2003). J Biol Chem 278: 37536–37544.

  • Shaul Y, Ben-Yehoyada M . (2005). Cell Res 15: 33–35.

  • Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, Ben-Neriah Y et al. (2001). Mol Cell Biol 21: 5869–5878.

  • Sionov RV, Moallem E, Berger M, Kazaz A, Gerlitz O, Ben-Neriah Y et al. (1999). J Biol Chem 274: 8371–8374.

  • Wu JJ, Afar DE, Phan H, Witte ON, Lam KS . (2002). Comb Chem High Throughput Screen 5: 83–91.

Download references

Acknowledgements

We are extremely grateful to Giulio Superti-Furga for the gift of plasmids expressing the c-Abl kinase, to Sonia Lain for ARF-expressing plasmid and antibody to Mark Saville for purified Hdm2 and to Frances Fuller-Pace for assistance with immunofluorescence microscopy. This work was supported by the Biomedical Research Centre (University of Dundee), the Association for International Cancer Research and Cancer Research UK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D W Meek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dias, S., Milne, D. & Meek, D. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF. Oncogene 25, 6666–6671 (2006). https://doi.org/10.1038/sj.onc.1209671

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209671

Keywords

This article is cited by

Search

Quick links